American Healthcare REIT, Inc. AHR

FY2025 · ended Dec 31, 2025 · Revenue $2.09B, +11.2% YoY · Filed Feb 27, 2026

American Healthcare REIT, Inc. (AHR) files with the SEC under industry code 6798, Real Estate Investment Trusts. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.1 billion and net income of $69.8 million. As of Jun 30, 2026 it held $156.9 million in cash and investments and $144.2 million in total debt.

Revenue (TTM)
$2.34B
+18.7% vs year-ago TTM
Net income (TTM)
$121.02M
+469.0% vs year-ago TTM
Operating cash flow (TTM)
$362.04M
+42.1% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$0.66
+406.3% vs year-ago TTM
Dividend per share (TTM)
$1.00
+0.0% vs year-ago TTM
Shares outstanding
188.03M
+19.3% vs prior year
Net cash
$12.71M
as of Jun 30, 2026
Operating margin
20.5%
FY 2026

Company profile

Industry
Real Estate Investment Trusts (SIC 6798)
Listed as
AHR (NYSE)
Fiscal year ends
December 31
Incorporated in
MD
Headquarters
Irvine, CA
SEC filer status
Large accelerated filer
SEC CIK
1632970
Former names
Griffin-American Healthcare REIT IV, Inc. (until Sep 30, 2021); Griffin-American Healthcare REIT 4, Inc. (until Oct 23, 2015)

Other Real Estate Investment Trusts companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$2.1B
$1.9B
$1.7B
$1.4B
$1.1B
Operating income
$415.2M
$363.5M
$306.8M
$302.0M
$213.3M
Net income
$69.8M
-$37.8M
-$71.5M
-$81.3M
-$47.8M
Diluted EPS
$0.42
-$0.29
-$1.08
-$1.24
-$0.95
Operating cash flow
$294.4M
$176.1M
$98.5M
$147.8M
$17.9M
Total assets
$5.4B
$4.5B
$4.6B
$4.8B
$4.6B
Total liabilities
$2.1B
$2.2B
$3.1B
$3.1B
$2.8B
Stockholders' equity
$3.3B
$2.3B
$1.3B
$1.4B
$1.6B
Cash and investments
$114.8M
$76.7M
$43.4M
$65.1M
$81.6M
Total debt
$169.5M
$165.4M
$225.6M
$273.2M
$145.6M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Sep 18, 2026 Sep 18, 2026
8-K Current report
Regulation FD disclosure
Sep 14, 2026 Sep 14, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 2, 2026 Sep 2, 2026
8-K Current report
Regulation FD disclosure
Sep 1, 2026 Sep 1, 2026
8-K Current report
Other events
Aug 24, 2026 Aug 20, 2026
8-K Current report
Other events
Aug 12, 2026 Aug 10, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.